CAY10404 is a selective inhibitor of the COX-2 enzyme, primarily utilized in research settings to study its role in inflammation, pain, and related signaling pathways in cellular processes. It is employed to investigate the effects of COX-2 modulation on cell behavior, particularly in studies related to cancer, arthritis, and other inflammatory disorders. Researchers use it to understand the mechanisms underlying disease progression and to identify potential therapeutic targets for anti-inflammatory and analgesic drugs. Its application in laboratory experiments helps in the development of novel treatments by providing insights into the biological functions of COX-2.